Monique J. Roobol
Monique J. Roobol
Erasmus University Medical Centre
Verified email at - Homepage
Cited by
Cited by
Screening and prostate-cancer mortality in a randomized European study
FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ...
New England Journal of Medicine 360 (13), 1320-1328, 2009
Mortality results from a randomized prostate-cancer screening trial
GL Andriole, ED Crawford, RL Grubb III, SS Buys, D Chia, TR Church, ...
New England Journal of Medicine 360 (13), 1310-1319, 2009
Prostate-cancer mortality at 11 years of follow-up
FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ...
New England Journal of Medicine 366 (11), 981-990, 2012
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, M Zappa, V Nelen, ...
The Lancet 384 (9959), 2027-2035, 2014
MRI-targeted or standard biopsy for prostate-cancer diagnosis
V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ...
New England Journal of Medicine 378 (19), 1767-1777, 2018
Magnetic resonance imaging–targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided …
IG Schoots, MJ Roobol, D Nieboer, CH Bangma, EW Steyerberg, ...
European urology 68 (3), 438-450, 2015
Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program
R Raaijmakers, WJ Kirkels, MJ Roobol, MF Wildhagen, FH Schrder
Urology 60 (5), 826-830, 2002
Active surveillance for low-risk prostate cancer worldwide: the PRIAS study
M Bul, X Zhu, R Valdagni, T Pickles, Y Kakehi, A Rannikko, A Bjartell, ...
European urology 63 (4), 597-603, 2013
Quality-of-life effects of prostate-specific antigen screening
EAM Heijnsdijk, EM Wever, A Auvinen, J Hugosson, S Ciatto, V Nelen, ...
New England Journal of Medicine 367 (7), 595-605, 2012
Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guerin, and …
RJ Sylvester, MA Brausi, WJ Kirkels, W Hoeltl, FC Da Silva, PH Powell, ...
European urology 57 (5), 766-773, 2010
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram
EW Steyerberg, MJ Roobol, MW Kattan, TH Van der Kwast, HJ De Koning, ...
The Journal of urology 177 (1), 107-112, 2007
Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly
RCN van den Bergh, S Roemeling, MJ Roobol, G Aus, J Hugosson, ...
European urology 55 (1), 1-8, 2009
Infectious complications and hospital admissions after prostate biopsy in a European randomized trial
S Loeb, S van den Heuvel, X Zhu, CH Bangma, FH Schröder, MJ Roobol
European urology 61 (6), 1110-1114, 2012
A risk-based strategy improves prostate-specific antigen–driven detection of prostate cancer
MJ Roobol, EW Steyerberg, R Kranse, T Wolters, RCN van den Bergh, ...
European urology 57 (1), 79-85, 2010
Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents
JE Sousa, MA Costa, A Abizaid, F Feres, AC Seixas, LF Tanajura, ...
Circulation 111 (18), 2326-2329, 2005
Prostate cancer mortality reduction by prostate-specific antigen–based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for …
MJ Roobol, M Kerkhof, FH Schröder, J Cuzick, P Sasieni, M Hakama, ...
European urology 56 (4), 584-591, 2009
Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care
O Ukimura, JA Coleman, A De La Taille, M Emberton, JI Epstein, ...
European urology 63 (2), 214-230, 2013
A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial
T Wolters, MJ Roobol, PJ van Leeuwen, RCN van den Bergh, ...
The Journal of urology 185 (1), 121-125, 2011
Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection
FH Jansen, RHN van Schaik, J Kurstjens, W Horninger, H Klocker, ...
European urology 57 (6), 921-927, 2010
The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation
E Soler, C Andrieu-Soler, E de Boer, JC Bryne, S Thongjuea, ...
Genes & development 24 (3), 277-289, 2010
The system can't perform the operation now. Try again later.
Articles 1–20